1887

Abstract

We constructed two recombinant nuclear polyhedrosis baculoviruses. (Sf9) cells containing these constructs produce carboxy-terminally truncated envelope E proteins representing dengue (DEN) virus serotypes 2 and 3. The two recombinant proteins contained their homologous signal sequences at the N terminus and were truncated by 71 and 74 amino acids at the C terminus, respectively. This allowed the translocation of the recombinant proteins to the endoplasmic reticulum followed by glycosylation processing and secretion into the extracellular medium. An additional unglycosylated form which was not secreted was detected inside the infected Sf9 cells. Sera from Swiss mice immunized with the infected Sf9 cell lysates gave a DEN cross-reactive response in ELISA and substantial amounts of neutralizing antibodies to the homologous virus. Similar antibody titres were obtained when the two recombinant proteins were inoculated concomitantly. BALB/c mice were vaccinated with three doses of the recombinant E proteins, taken as monovalent or bivalent immunogens, and challenged with mouse-adapted DEN-2 virus. DEN-2 E protein induced a good protection (90 %) against lethal encephalitis and recombinant DEN-3 E protein gave a substantial cross-protection (54%). Eighty-two percent of the mice immunized with a mixture of both recombinant E proteins survived the DEN-2 virus challenge.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-7-1569
1994-07-01
2022-01-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/7/JV0750071569.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-7-1569&mimeType=html&fmt=ahah

References

  1. Barme M., Bres P., Hery G., Robin V. 1970; Technique des laboratoires des virus et des arbovirus. Rapport sur le Fonctionnement Technique de l’Institut Pasteur de Dakar pp. 159–244
    [Google Scholar]
  2. Brandt W. E. 1990; Development of dengue and Japanese encephalitis vaccines. Journal of Infectious Diseases 162:577–583
    [Google Scholar]
  3. Calisher C. H., Karabatsos N., Dalrymple J. M., Shope R. E., Porterfield J. S., Westaway E. G., Brandt W. E. 1989; Antigenic relationships between flaviviruses as determined by crossneutralization tests with polyclonal antisera. Journal of General Virology 70:37–43
    [Google Scholar]
  4. Chungue E., Deubel V., Cassar O., Laille M., Martin P. M. V. 1993; Molecular epidemiology of dengue 3 viruses and genetic relatedness among dengue 3 strains isolated from patients with mild or severe form of dengue fever in French Polynesia. Journal of General Virology 74:2765–2770
    [Google Scholar]
  5. Despres P., Cahour A., Wychowski C., Girard M., Bouloy M. 1988; Expression of yellow fever virus envelope protein using hybrid SV40/yellow fever viruses. Annales de l’Institut Pasteur/Virologie 139:59–67
    [Google Scholar]
  6. Desprès P., Dietrich J., Girard M., Bouloy M. 1991; Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice. Journal of General Virology 72:2811–2816
    [Google Scholar]
  7. Deubel V., Kinney R. M., Trent D. W. 1986; Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. Virology 155:365–377
    [Google Scholar]
  8. Deubel V., Laille M., Hugnot J. P., Chungue E., Guesdon J. L., Drouet M. T., Bassot S., Chevrier D. 1990; Identification of dengue sequences by genomic amplification: rapid diagnosis of dengue virus serotype in peripheral blood. Journal of Virological Methods 30:41–54
    [Google Scholar]
  9. Deubel V., Bordier M., Mégret F., Gentry M. K., Schlesinger J. J., Girard M. 1991; Processing, secretion, and immuno- reactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses. Virology 180:442–447
    [Google Scholar]
  10. Fonseca B. A. L., Pincus S., Shope R. E., Paoletti E., Mason P. W. 1994; Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine 12:279–285
    [Google Scholar]
  11. Feighny R., Burrous J., Mccown J., Hoke C., Putnak R. 1992; Purification of native dengue-2 viral proteins and the ability of purified proteins to protect mice. American Journal of Tropical Medicine and Hygiene 47:405–412
    [Google Scholar]
  12. Gruenberg A., Woo W. S., Biedrzycka A., Wright P. J. 1988; Partial nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue virus type 2, New Guinea C and PUO-218 strains. Journal of General Virology 69:1391–1398
    [Google Scholar]
  13. Halstead S. B. 1988; Pathogenesis of dengue: challenges to molecular biology. Science 239:476–481
    [Google Scholar]
  14. Henchal E. A., Putnak J. R. 1990; The dengue viruses. Clinical Microbiology Renews 3:376–396
    [Google Scholar]
  15. Hoke C. H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L, Gringrinch J. B., Latendresse J., Fukai K., Burke D. S. 1988; Protection against Japanese encephalitis by inactivated vaccines. New England Journal of Medicine 319:608–614
    [Google Scholar]
  16. Hunt P. 1993; Thai trial for dengue vaccine. New ScientistJanuary16 p. 9
    [Google Scholar]
  17. Jan L. R., Yang C. S., Henchal L. S., Sumiyoshi H., Summers P. L., Dubois D. R., Lai C. J. 1993; Increased immunogenicity and protective efficacy in outbred and inbred mice by strategic carboxy-terminal truncation of Japanese encephalitis virus envelope glycoprotein. American Journal of Tropical Medicine and Hygiene 48:412–423
    [Google Scholar]
  18. Kitts P. A., Ayres M. D., Possee R. D. 1990; Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors. Nucleic Acids Research 18:5667–5672
    [Google Scholar]
  19. Kuroda K., Geyer H., Geyer R., Doerfler W., Klenk H.-D. 1990; The oligosaccharides of influenza virus hemagglutinin expressed in insect cells by a baculovirus vector. Virology 174:418–429
    [Google Scholar]
  20. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
  21. Lai C. J., Zhang Y. M., Bray M., Chanock R. 1989; Use of dengue virus structural proteins and non structural protein NS1 produced by recombinant baculovirus for immunization against dengue virus infection. In Vaccines’89 pp. 351–356 Lerner R. A., Ginsberg H. S., Chanock R. M., Brown F. Edited by New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  22. Mccown J., Cochran M., Putnak R., Feighny R., Burrous J., Henchal E., Hoke C. 1990; Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine. American Journal of Tropical Medicine and Hygiene 42:491–499
    [Google Scholar]
  23. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  24. Mason P. W., Pincus S., Fournier M. J., Mason T. L., Shope R. E., Paoletti E. 1991; Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180:294–305
    [Google Scholar]
  25. Matsuura Y., Possee R. D., Overton H. A., Bishop D. H. L. 1987; Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. Journal of General Virology 68:1233–1250
    [Google Scholar]
  26. Mégret F., Hugnot P. J., Falconar A., Gentry M. K., Morens D. M., Murray J. M., Schlesinger J. J., Wright P. J., Young P., Van Regenmortel M. H. V., Deubel V. 1992; Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 187:480–491
    [Google Scholar]
  27. Men R., Bray M., Lai C.-J. 1991; Carboxy-terminally truncated dengue virus envelope glycoproteins expressed on the cell surface and secreted extracellularly exhibit increased immunogenicity in mice. Journal of Virology 65:1400–1407
    [Google Scholar]
  28. Monath T. P., Wands J. R., Hill L. J., Brown N. V., Marciniak R. A., Wong M. A., Gentry M. K., Burke D. S., Grant J. A., Trent D. W. 1986; Geographical classification of dengue-2 virus strains by antigen signature analysis. Virology 154:313–324
    [Google Scholar]
  29. Okuno Y., Okamoto Y., Yamada A., Baba K., Yabuuchi H. 1987; Effect of current Japanese encephalitis vaccine on different strains of Japanese encephalitis virus. Vaccine 5:128–132
    [Google Scholar]
  30. Osatomi K., Sumiyoshi H. 1990; Complete nucleotide sequence of dengue type 3 virus genome RNA. Virology 176:643–647
    [Google Scholar]
  31. Pincus S., Mason P. W., Konishi E., Fonseca B. A., Shope R. E., Rice C. M., Paoletti E. 1992; Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology 187:290–297
    [Google Scholar]
  32. Possee R. D., Howard S. C. 1987; Analysis of the polyhedrin gene promoter of the Autographa californica nuclear polyhedrosis virus. Nucleic Acid Research 24:10233–10248
    [Google Scholar]
  33. Putnak R., Feighny R., Burrous J., Cochran M., Hackett C., Smith G., Hoke C. 1991; Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge. American Journal of Tropical Medicine and Hygiene 45:159–167
    [Google Scholar]
  34. Rico-Hesse R. 1990; Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology 174:479–493
    [Google Scholar]
  35. Rosen L. 1986; The natural history of Japanese encephalitis virus. Annual Review of Microbiology 40:395–414
    [Google Scholar]
  36. Rothman A. L., Kurane I., Lai C.-J., Bray M., Falgout B., Men R., Ennis F. A. 1993; Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes. Journal of Virology 67:801–806
    [Google Scholar]
  37. Ruiz-Linarès A., Cahour A., Desprès P., Girard M., Bouloy M. 1989; Processing of yellow fever virus polyprotein: role of cellular proteases in maturation of the structural proteins. Journal of Virology 63:4199–4209
    [Google Scholar]
  38. Schlesinger J. J., Brandriss M. W., Putnak J. R., Walsh E. E. 1990; Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. Journal of General Virology 71:593–599
    [Google Scholar]
  39. Stephenson J. R. 1988; Flavivirus vaccines. Vaccine 6:471–480
    [Google Scholar]
  40. Summers M. D., Smith G. E. 1987; A manual of methods for baculovirus vectors and insect cell culture procedure. Texas Agricultural Experiment Station Bulletin1555
    [Google Scholar]
  41. Wengler G., Wengler G., Nowak T., Wahn K. 1987; Analysis of the influence of proteolytic cleavage on the structural organization of the surface of the West Nile flavivirus leads to the isolation of a protease-resistant oligomer from the viral surface. Virology 160:210–219
    [Google Scholar]
  42. Yamshchikov V. F., Compans R. W. 1993; Regulation of the late events in flavivirus protein processing and maturation. Virology 192:38–51
    [Google Scholar]
  43. Yasuda A., Kimura-Kuroda J., Ogimoto M., Miyamoto M., Sata T., Sato T., Takamura C., Kurata T., Kojima A., Yasui K. 1990; Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express preM and E glycoproteins of Japanese encephalitis virus. Journal of Virology 64:2788–2790
    [Google Scholar]
  44. Zhang Y. M., Hayes E. P., Mccarty T. C., Dubois D. R., Summers P. L., Eckels K. H., Chanock R. M., Lai C. J. 1988; Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. Journal of Virology 62:3027–3031
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-75-7-1569
Loading
/content/journal/jgv/10.1099/0022-1317-75-7-1569
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error